-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Irritable bowel syndrome (IBS) is a functional bowel disease
Irritable bowel syndrome management
The study included 45 IBS patients who were randomly divided into a probiotic group (n = 24) and a control group (n = 21), and received conventional treatment with or without probiotics for 28 days
The results showed that on the 28th day, the IBS-symptom severity score (P <0.
In summary, the results of the study show that, compared with conventional therapies, the adjuvant use of probiotics and conventional therapies has not shown additional clinical effects in the management of IBS
Original source:
Haiyan Xu, et al.
Adjunctive treatment with probiotics partially alleviates symptoms and reduces inflammation in patients with irritable bowel syndrome
in this message